Evidence map›Paper›PMID 27048802›Full record

ArticlemBio2016

Characterization of a Novel Orthomyxo-like Virus Causing Mass Die-Offs of Tilapia.

Eran Bacharach, Nischay Mishra, Thomas Briese, Michael C Zody, Japhette Esther Kembou Tsofack, Rachel Zamostiano, Asaf Berkowitz, James Ng, Adam Nitido, André Corvelo and 8 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 275 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Exploring the Virome of Nile Tilapia (Pathogens (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. A New Cell Line from the Brain of Red Hybrid Tilapia (Animals : an open access journal from MDPI · 2024
    Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Eran BacharachDepartment of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Nischay MishraCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Thomas BrieseCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Michael C ZodyNew York Genome Center, New York, New York, USA.
Japhette Esther Kembou TsofackDepartment of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Rachel ZamostianoDepartment of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Asaf BerkowitzDepartment of Poultry and Fish Diseases, The Kimron Veterinary Institute, Bet Dagan, Israel.
James NgCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Adam NitidoCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
André CorveloNew York Genome Center, New York, New York, USA.
Nora C ToussaintNew York Genome Center, New York, New York, USA.
Sandra Cathrine Abel NielsenCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Mady HornigCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Jorge Del PozoEaster Bush Pathology, The Royal (Dick) School of Veterinary Studies and The Roslin Institute, University of Edinburgh, Midlothian, Scotland.
Toby BloomNew York Genome Center, New York, New York, USA.
Hugh FergusonMarine Medicine Program, Pathobiology, School of Veterinary Medicine, St. George's University, Grenada, West Indies.
Avi EldarDepartment of Poultry and Fish Diseases, The Kimron Veterinary Institute, Bet Dagan, Israel eldar@int.gov.il wil2001@cumc.columbia.edu.
W Ian LipkinCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA eldar@int.gov.il wil2001@cumc.columbia.edu.
Columbia University · USNew York Genome Center · USTel Aviv University · ILRoslin Institute · GBSt. George's University · GD

Funding

Translational CoreU19AI109761 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARIC, RALPH S · 2014 to 2018
$32.6M
NIAID NIH HHS AI109761NIAID NIH HHS U19 AI109761
6 · The paper itself

Abstract

unlabelledTilapia are an important global food source due to their omnivorous diet, tolerance for high-density aquaculture, and relative disease resistance. Since 2009, tilapia aquaculture has been threatened by mass die-offs in farmed fish in Israel and Ecuador. Here we report evidence implicating a novel orthomyxo-like virus in these outbreaks. The tilapia lake virus (TiLV) has a 10-segment, negative-sense RNA genome. The largest segment, segment 1, contains an open reading frame with weak sequence homology to the influenza C virus PB1 subunit. The other nine segments showed no homology to other viruses but have conserved, complementary sequences at their 5' and 3' termini, consistent with the genome organization found in other orthomyxoviruses. In situ hybridization indicates TiLV replication and transcription at sites of pathology in the liver and central nervous system of tilapia with disease. IMPORTANCE: The economic impact of worldwide trade in tilapia is estimated at $7.5 billion U.S. dollars (USD) annually. The infectious agent implicated in mass tilapia die-offs in two continents poses a threat to the global tilapia industry, which not only provides inexpensive dietary protein but also is a major employer in the developing world. Here we report characterization of the causative agent as a novel orthomyxo-like virus, tilapia lake virus (TiLV). We also describe complete genomic and protein sequences that will facilitate TiLV detection and containment and enable vaccine development.

Indexed as

Amino Acid SequenceAnimalsEcuadorFish DiseasesIsraelOpen Reading FramesOrthomyxoviridaeOrthomyxoviridae InfectionsSequence AlignmentTilapiaViral ProteinsViral Proteins

Identifiers

PMID27048802
PMCPMC4959514
OpenAlexW2318523090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.